4
Changes in Ownership
Edgewise Therapeutics, Inc. Filed Acc 0001562180-25-001024
Chief Business Officer sold 10,000 shares at $30.03 ($300,300)
- Chief Business Officer acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Derakhshan Behrad · Chief Business Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-02-05 | Exercise or conversion : show line 1 in the form | +10,000 | $1.93 | $19,300 | 26,837 | D |
| 2025-02-05 | Sale : show line 2 in the form | −10,000 | $30.03 | $300,300 | 16,837 | D |
| Open-market sales · 10,000 sh · avg $30.03 · $300,300 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-02-05 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −10,000 | 92,929 | D |
Loading xslF345X05/primarydocument.xml…